Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 2681571

Using structural power sources to increase influence.

C B Hoezel
View original source ↗Export metadata ↓

Abstract

To be more effective in the health care system of the 1990s, nursing administrators must understand organizational sources of structural power. After analyzing structural power sources, the nursing administrator must develop a plan to use them and, finally, must be willing to acquire that power which is available. The author explores three sources of structural power: centrality, control of uncertainty and control over resources, and analyzes their relevance for nursing administrators.

Explore related subjects

Adaptation, PsychologicalAdministrative PersonnelCommunicationHumansInterprofessional RelationsNurse AdministratorsNursing Service, HospitalOrganizational InnovationPlanning TechniquesPower, PsychologicalSpecializationJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

C B Hoezel. 1989. Using structural power sources to increase influence.. https://pubmed.ncbi.nlm.nih.gov/2681571/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1999

Dehydroepiandrosterone treatment of midlife dysthymia.

BACKGROUND: This study evaluated the efficacy of the adrenal androgen, dehydroepiandrosterone, in the treatment of midlife-onset dysthymia. METHODS: A double-blind, randomized crossover treatment study was performed as follows: 3 weeks on 90 mg dehydroepiandrosterone, 3 weeks on 450 mg dehydroepiandrosterone, and 6 weeks on placebo. Outcome measures consisted of the following. Cross-sectional self-ratings included the Beck Depression Inventory, and visual analogue symptom scales. Cross-sectional objective ratings included the Hamilton Depression Rating Scale, the Cornell Dysthymia Scale and a cognitive test battery. Seventeen men and women aged 45 to 63 years with midlife-onset dysthymia participated in this study. Response to dehydroepiandrosterone or placebo was defined as a 50% reduction from baseline in either the Hamilton Depression Rating Scale or the Beck Depression Inventory. RESULTS: In 15 patients who completed the study, a robust effect of dehydroepiandrosterone on mood was observed compared with placebo. Sixty percent of the patients responded to dehydroepiandrosterone at the end of the 6-week treatment period compared with 20% on placebo. A significant response was seen after 3 weeks of treatment on 90 mg per day. The symptoms that improved most significantly were anhedonia, loss of energy, lack of motivation, emotional "numbness," sadness, inability to cope, and worry. Dehydroepiandrosterone showed no specific effects on cognitive function or sleep disturbance, although a type II error could not be ruled out. CONCLUSIONS: This pilot study suggests that dehydroepiandrosterone is an effective treatment for midlife-onset dysthymia.

Adaptation, Psychological↗
PubMed1999

Assessment of patients' reporting of pain: an integrated perspective.

A common assumption about pain is that it always results from the presence of underlying organic pathology. In the absence of objective pathology, an individual's report of pain may be ascribed to psychological causes. There is a wide variation in patient's experience of pain and organic factors alone cannot explain individual differences in patients' reports. Assessment of patients who report pain requires attention to psychosocial, behavioural, and organic factors. We describe a comprehensive approach to the assessment of psychological and behavioural variables that affect patients' reports of pain. We counter the duality of the somatogenic versus psychogenic perspective and suggest a more integrated assessment that encompasses not only the severity of pain and related physical pathology but also the person who is reporting the presence of pain.

Adaptation, Psychological↗